Novel Pathway for Intercepting Granular Exocytosis: A13 Engages APLNR to Drive FBXO28 ‐Mediated Ubiquitination and Proteasomal Clearance of Rab27a in Allergic Inflammation
Immunology · 2026-08 · 178 (4) · 674-684
DOI: 10.1111/imm.70135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, online erschienen am 01.05.2026. Verfasst von Gaohui Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice Medicine, Third Affiliated Hospital of Shenzhen University, Shenzhen, China. Hauptthemen laut MEDLINE: F-Box Proteins, Exocytosis, Proteasome Endopeptidase Complex, rab GTP-Binding Proteins. Die Arbeit nennt 15 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Key Medical Discipline Construction Fund, Science, Technology and Innovation Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Allergic airway inflammation (AA) is primarily driven by the activation of mast cells and eosinophils, with granular exocytosis serving as a key source of pro‐allergic mediators that amplify pathological responses. This unmet need highlights the importance of identifying novel, pathway‐specific therapeutic targets to improve disease management. A dust mite extract (DME)‐induced murine model of AA was used to assess intranasal A13 (1 mg/kg daily) efficacy; human EoL‐1 eosinophils and murine P815 mast cells were stimulated with PMA/ionomycin (P&I) to induce exocytosis. In DME‐induced murine AA, intranasal A13 reduced lung inflammation by 58% ( p < 0.01), serum sIgE by 73% ( p < 0.001), and BALF Th2 cytokines (IL‐4/IL‐5/IL‐13) by 65%–80% ( p < 0.001), while restoring BALF IFN‐γ ( p < 0.01). A13 inhibited granular mediator release: in P&I‐challenged WT mice, it reduced BALF eosinophil peroxidase (EPX) by 81% and mast cell protease‐1 by 85%, but had no effect in APLNR⁻ / ⁻ mice ( p > 0.05). Mechanistically, P&I induced Rab27a upregulation (P815: 3.2‐fold; EoL‐1: 2.8‐fold), which A13 reversed in vitro; in vivo, A13 lowered lung granulocyte Rab27a by 2.5–3.1‐fold ( p < 0.001). A13 engaged APLNR to recruit FBXO28, promoting K48‐linked Rab27a ubiquitination and proteasomal degradation. APLNR knockdown or MG132 treatment abrogated A13's effects, while A13 enhanced FBXO28‐Rab27a complex formation by 4.7‐fold ( p < 0.001)—an interaction undetectable in APLNR −/− cells. Intranasal A13 exhibits localised action, effectively suppressing allergic inflammation without broad systemic immunosuppression, making it a promising candidate for development as a topical biologic to treat allergic airway diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Practice Medicine, Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
- State Key Laboratory of Respiratory Diseases Allergy Division at Shenzhen University and Institute of Allergy & Immunology, Shenzhen University School of Medicine, Shenzhen Key Laboratory of Allergy & Immunology, Shenzh…
ORCID-Profile: Pingchang Yang
Förderung
- National Natural Science Foundation of China
- Shenzhen Key Medical Discipline Construction Fund
- Science, Technology and Innovation Commission of Shenzhen Municipality
- China Postdoctoral Science Foundation
- Shenzhen Medical Research Fund
Zitieren
APA
Wu, G., Ye, Y., Duan, J., Li, M., Liao, Y., Yang, P., Huang, Q., & Liu, Y. (2026). Novel Pathway for Intercepting Granular Exocytosis: A13 Engages APLNR to Drive FBXO28 ‐Mediated Ubiquitination and Proteasomal Clearance of Rab27a in Allergic Inflammation. Immunology, 178(4), 674-684. https://doi.org/10.1111/imm.70135
Vancouver
Wu G, Ye Y, Duan J, Li M, Liao Y, Yang P, et al. Novel Pathway for Intercepting Granular Exocytosis: A13 Engages APLNR to Drive FBXO28 ‐Mediated Ubiquitination and Proteasomal Clearance of Rab27a in Allergic Inflammation. Immunology. 2026;178(4):674-684. doi:10.1111/imm.70135
BibTeX
@article{Wu2026,
author = {Wu, Gaohui and Ye, Yanyu and Duan, Jiaqi and Li, Minyao and Liao, Yun and Yang, Pingchang and Huang, Qinmiao and Liu, Yu},
title = {Novel Pathway for Intercepting Granular Exocytosis: A13 Engages APLNR to Drive FBXO28 ‐Mediated Ubiquitination and Proteasomal Clearance of Rab27a in Allergic Inflammation},
journal = {Immunology},
year = {2026},
volume = {178},
number = {4},
pages = {674--684},
doi = {10.1111/imm.70135}
}
EUVIMED